Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kathinka E. Pitman, Espen Rusten, Alexandr Kristian & Eirik Malinen. (2015) Variability of dynamic 18F-FDG-PET data in breast cancer xenografts. Acta Oncologica 54:9, pages 1399-1407.
Read now
Read now
Xingchen Wu, Hannu Pertovaara, Pasi Korkola, Martine Vornanen, Ritva Järvenpää, Prasun Dastidar, Hannu Eskola & Pirkko-Liisa Kellokumpu-Lehtinen. (2014) Early interim PET/CT predicts post-treatment response in diffuse large B-cell lymphoma. Acta Oncologica 53:8, pages 1093-1099.
Read now
Read now
Jan Rødal, Espen Rusten, Åste Søvik, Hege Kippenes Skogmo & Eirik Malinen. (2013) Functional imaging to monitor vascular and metabolic response in canine head and neck tumors during fractionated radiotherapy. Acta Oncologica 52:7, pages 1293-1299.
Read now
Read now
Sara Carvalho, Ralph T. H. Leijenaar, Emmanuel Rios Velazquez, Cary Oberije, Chintan Parmar, Wouter van Elmpt, Bart Reymen, Esther G. C. Troost, Michel Oellers, Andre Dekker, Robert Gillies, Hugo J. W. L. Aerts & Philippe Lambin. (2013) Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer. Acta Oncologica 52:7, pages 1398-1404.
Read now
Read now
Ingerid Skjei Knudtsen, Jan Rødal, Odd Terje Brustugun, Åslaug Helland, Arne Skretting & Eirik Malinen. (2011) Dynamic respiratory gated 18FDG-PET of lung tumors – a feasibility study. Acta Oncologica 50:6, pages 889-896.
Read now
Read now
Articles from other publishers (7)
Feng‑Chun Zhang, Hai‑Yan Xu, Jian‑Jun Liu, Yuan‑Fan Xu, Bin Chen, Yi‑Jin Yang, Ning‑Ning Yan, Shao‑Li Song, Yu‑Mei Lin & Ying‑Chun Xu. (2018) 18F‑FDG PET/CT for the early prediction of the response rate and survival of patients with recurrent or metastatic breast cancer. Oncology Letters.
Crossref
Crossref
Esra Ciftci, Bulent Turgut, Ali Cakmakcilar & Seyit A. Erturk. (2017) Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions. Nuclear Medicine Communications 38:9, pages 788-794.
Crossref
Crossref
Andrea d’Amico. (2014) Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy. La radiologia medica 120:4, pages 345-351.
Crossref
Crossref
Yong-il Kim, Gi Jeong Cheon, Jin Chul Paeng, Jeong Yeon Cho, Keon Wook Kang, June-Key Chung, Euishin Edmund Kim & Dong Soo Lee. (2014) Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate–high risk adrenal incidentaloma. Nuclear Medicine Communications 35:6, pages 606-612.
Crossref
Crossref
Yong-il Kim, Hyun Guy Kang, Seok-ki Kim, June Hyuk Kim & Han Soo Kim. (2013) Clinical outcome prediction of percutaneous cementoplasty for metastatic bone tumor using 18F-FDG PET-CT. Annals of Nuclear Medicine 27:10, pages 916-923.
Crossref
Crossref
Pankaj K. Singh, Randall E. Brand & Kamiya Mehla. (2012) MicroRNAs in pancreatic cancer metabolism. Nature Reviews Gastroenterology & Hepatology 9:6, pages 334-344.
Crossref
Crossref
John J. Sunderland & Mark T. Madsen. (2011) Features to Consider When Selecting New PET/CT Systems. Journal of the American College of Radiology 8:3, pages 211-213.
Crossref
Crossref